SEARCH

SEARCH BY CITATION

References

  • 1
    Silverberg E: Cancer statistics, 1985. CA 35: 1935, 1985.
  • 2
    Kopf AW, Rigel DS, Friedman RJ: The rising incidence and mortality rate of malignant melanoma. J Dermatol Surg Oncol 8: 760761, 1982.
  • 3
    Mihm MC Jr, Fitzpatrick TB, Brown MML, et al: Early detection of primary cutaneous malignant melanoma. A color atlas. N Engl J Med 289: 989996, 1973.
  • 4
    Ackerman AB: Clinical diagnosis of malignant melanoma in situ, in AckermanAB (ed): Pathology of Malignant Melanoma. New York, Masson Publishing USA, Inc, 1981, pp 5758.
  • 5
    Sober AJ, Fitzpatrick TB, Mihm MC, et al: Early recognition of cutaneous melanoma. JAMA 242: 27952799, 1979.
  • 6
    Ackerman AB: Malignant melanoma: A unifying concept. Hum Pathol 11: 591595, 1980.
  • 7
    Breslow A: Prognostic factors in the treatment of cutaneous melanoma. J Cutan Pathol 6: 208212, 1979.
  • 8
    Fitzpatrick TB: Early recognition of primary cutaneous melanoma. Hosp Pract 17: 6775, 1982.
  • 9
    Clark WH Jr: Clinical diagnosis of cutaneous malignant melanoma (editorial). JAMA 236: 484485, 1976.
  • 10
    Clark WH Jr, From L, Bernardino EA, et al: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29: 705727, 1969.
  • 11
    Breslow A: Thickness, cross-sectional areas, and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902908, 1970.
  • 12
    Balch CM, Murad TM, Soong SJ, et al: A multifactorial analysis of melanoma: Prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg 188: 732742, 1978.
  • 13
    McGovern VJ, Shaw HM, Milton GW, et al: Prognostic significance of the histological features of malignant melanoma. Histopathology 3: 385393, 1979.
  • 14
    Day CL Jr, Mihm MC Jr, Lew RA, et al: Cutaneous malignant melanoma: Prognostic guidelines for physicians and patients. CA 32: 113122, 1982.
  • 15
    Breslow A, Cascinelli N, van der Esch EP, et al: Stage I melanoma of the limbs: Assessment of prognosis by levels of invasion and maximum thickness. Tumori 64: 273284, 1978.
  • 16
    Funk W, Schmoeckel C, Hölzel D, et al: Prognostic classification of malignant melanoma by clinical criteria. Br J Dermatol 111: 129138, 1984.
  • 17
    Wick MM, Sober AJ, Fitzpatrick TJ, et al: Clinical characteristics of early cutaneous melanoma. Cancer 45: 26842686, 1980.
  • 18
    Roses DF, Harris MN, Ackerman AB: Diagnosis and Management of Cutaneous Malignant Melanoma. Philadelphia, WB Saunders Co, 1983, pp 126129.
  • 19
    Balch CM, Milton GW, Shaw HM, et al: Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide. Philadelphia, JB Lippincott Co, 1985, pp 6370.
  • 20
    NYU Melanoma Cooperative Group, unpublished observations, 1984.
  • 21
    KopfAW, BartRS, Rodríguez-SainsRS, et al (eds): Malignant Melanoma. New York, Masson Publishing USA, Inc, 1979, pp 152153.
  • 22
    Lyall D: Malignant melanoma in infancy (letter). JAMA 202: 1153, 1967.
  • 23
    Trozak DJ, Rowland WD, Hu F: Metastatic malignant melanoma in prepubertal children. Pediatrics 55: 191204, 1975.
  • 24
    Kaplan EN: The risk of malignancy in large congenital nevi. Plast Reconstr Surg 53: 421428, 1974.
  • 25
    Mark GJ, Mihm MC, Liteplo MG, et al: Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol 4: 395418, 1973.
  • 26
    Walton RG, Jacobs AH, Cox AJ: Pigmented lesions in newborn infants. Br J Dermatol 95: 389396, 1976.
  • 27
    Kopf AW, Bart RS, Hennessey P: Congenital nevocytic nevi and malignant melanomas. J Am Acad Dermatol 1: 123130, 1979.
  • 28
    Rhodes AR, Wood WC, Sober AJ, et al: Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg 67: 782790, 1981.
  • 29
    KopfAW, BartRS, Rodríguez-SainsRS, et al (eds): Malignant Melanoma. New York, Masson Publishing USA, Inc, 1979, pp 13.
  • 30
    CutlerSJ, YoungJLJr (eds): Third National Cancer Survey: Incidence Data. Natl Cancer Inst Monogr 41. DHEW Publication No. (NIH) 75–787. Bethesda, Md, National Cancer Institute, 1975.
  • 31
    Jones RE Jr, Cash ME, Ackerman AB: Malignant melanomas mistaken histologically for junctional nevi, in AckermanAB (ed): Pathology of Malignant Melanoma. New York, Masson Publishing USA, Inc, 1981, pp 93106.
  • 32
    Ackerman AB, Su WPD: The histology of cutaneous malignant melanoma, in KopfAW, BartRS, Rodríguez-SainsRS, et al (eds): Malignant Melanoma. New York, Masson Publishing USA, Inc, 1979, pp 25147.
  • 33
    Gumport SL, Harris MN, Kopf AW: Diagnosis and management of common skin cancers. CA 31: 7990, 1981.
  • 34
    Rigel DS, Friedman RJ: Clinical management of patients with dysplastic and congenital nevi. Dermatol Clin 3: 251255, 1985.
  • 35
    Clark WH Jr, Reimer RR, Greene M, et al: Origin of familial malignant melanomas from heritable melanocytic lesions. “The B-K Mole syndrome”. Arch Dermatol 114: 732738, 1978.
  • 36
    Elder DE, Greene MH, Bondi EE, et al: Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome, in AckermanAB (ed): Pathology of Malignant Melanoma. New York, Masson Publishing USA, Inc, 1981, pp 185215.
  • 37
    Greene MH, Fraumeni JF: The hereditary variant of malignant melanoma, in ClarkWHJr, GoldmanLI, MastrangeloMJ (eds): Human Malignant Melanoma. New York, Grune & Stratton, Inc, 1979, pp 139166.
  • 38
    Lynch HT, Fusaro RM, Danes BS, et al: A review of hereditary malignant melanoma including biomarkers in familial atypical multiple mole melanoma syndrome. Cancer Genet Cytogenet 8: 325358, 1983.
  • 39
    Lynch HT, Fusaro RM, Pester J, et al: Familial atypical multiple mole melanoma (FAMMM) syndrome: Genetic heterogeneity and malignant melanoma. Br J Cancer 42: 5870, 1980.
  • 40
    Greene MH: The dysplastic nevus syndrome. New York, The Melanoma Letter of the Skin Cancer Foundation 1: 2, 1982.
  • 41
    Friedman RJ, Heilman ER, Rigel DS, et al: The dysplastic nevus: Clinical and pathological features. Dermatol Clin 3: 239249, 1985.
  • 42
    Rhodes AR, Melski JW: Small congenital nevocellular nevi and the risk of cutaneous melanoma. J Pediatr 100: 219224, 1982.
  • 43
    Rhodes AR, Sober AJ, Day CL, et al: The malignant potential of small congenital nevocellular nevi. An estimate of association based on a histologic study of 234 primary cutaneous melanomas. J Am Acad Dermatol 6: 230241, 1982.
  • 44
    Arons MS, Hurwitz S: Congenital nevocellular nevus: A review of the treatment controversy and a report of 46 cases. Plast Reconstr Surg 72: 355365, 1983.
  • 45
    Gellen GA, Kopf AW, Garfinkel L: Malignant melanoma: A controlled study of possible associated factors. Arch Dermatol 99: 4348, 1969.
  • 46
    Kraemer KH: Xeroderma pigmentosum, in DemisDJ, McGuireJ (eds): Clinical Dermatology, vol 4, unit 19–7. Philadelphia, Harper & Row Publishers, 1984.
  • 47
    Kopf AW, Kripke ML, Stern RS: Sun and malignant melanoma. J Am Acad Dermatol 11: 674684, 1984.
  • 48
    Lew RA, Sober AJ, Cook N, et al: Sun exposure habits in patients with cutaneous melanoma: A case control study. J Dermatol Surg Oncol 9: 981986, 1983.
  • 49
    Rigel DS, Friedman RJ, Kopf AW: Risk factors for the development of malignant melanoma, in Proceedings of the National Clinical Dermatology Conference. Chicago, American Academy of Dermatology, 1984.
  • 50
    Holman CDJ, Armstrong BK: Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenetic types. J Natl Cancer Inst 73: 7582, 1984.
  • 51
    Davis N: Modern concepts of melanoma and its management. Ann Plast Surg 1: 628629, 1978.
  • 52
    Leis HP Jr: The diagnosis of breast cancer. CA 27: 209231, 1977.